Physician profile
Kent P Bashford
NPI 1346243714
$5,111.98
in general payments reported to CMS, 2019-2025
23 companies · $749 in 2025
The $749 reported for 2025 was more than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $332 · 2021: $455 · 2022: $1,708 · 2023: $596 · 2024: $787 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,092 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,092.49 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $1,505.98 | 2021-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Glaukos Corporation | $1,380.05 | 2019-2025 | Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro Bypass System, Istent Infinite |
| Rxsight INC | $518.62 | 2021-2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Allergan, INC. | $444.05 | 2019-2022 | |
| Alcon Vision LLC | $327.44 | 2019-2025 | Clareon, Hydrus Microstent |
| Abbvie INC. | $244.87 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Ivantis, INC | $110.57 | 2020-2021 | |
| Akorn, INC. | $109.95 | 2019-2020 | |
| Sight Sciences, INC. | $99.48 | 2020-2025 | Sion Surgical Instrument, Omni Surgical System |
| Thea Pharma INC. | $93.43 | 2022 | |
| Aerie Pharmaceuticals, INC. | $40.02 | 2019 | |
| Mallinckrodt Hospital Products INC. | $37.18 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.85 | 2020-2021 | |
| Shire North American Group INC | $31.75 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $26.64 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nova Eye, INC. | $23.67 | 2024 | |
| Novartis Pharmaceuticals Corporation | $21.59 | 2020 | |
| Bausch & Lomb Americas INC. | $21.51 | 2024 | Miebo, Vyzulta |
| Biotissue Holdings INC. | $21.23 | 2025 | |
| Akorn Operating Company LLC | $16.27 | 2021 | |
| Travere Therapeutics, INC. | $0.83 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Bashford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.